• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有和无冠状动脉疾病患者心房颤动的不同危险因素:BOREAS-CAG注册研究数据的横断面分析

Distinct risk factors of atrial fibrillation in patients with and without coronary artery disease: a cross-sectional analysis of the BOREAS-CAG Registry data.

作者信息

Murakami Naoto, Tanno Masaya, Kokubu Nobuaki, Nishida Junichi, Nagano Nobutaka, Ohnishi Hirofumi, Akasaka Hiroshi, Miki Takayuki, Tsuchihashi Kazufumi, Miura Tetsuji

机构信息

Department of Cardiovascular, Renal and Metabolic Medicine , Sapporo Medical University School of Medicine , Sapporo , Japan.

Department of Public Health, Sapporo Medical University School of Medicine, Sapporo , Japan.

出版信息

Open Heart. 2017 Jan 16;4(1):e000573. doi: 10.1136/openhrt-2016-000573. eCollection 2017.

DOI:10.1136/openhrt-2016-000573
PMID:28123767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5255559/
Abstract

OBJECTIVE

Although risk factors of atrial fibrillation (AF) in the general population have been characterised, their impacts on patients with specific diseases are unclear. Our aim was to determine whether risk factors of AF are different in patients with and those without coronary artery disease (CAD).

METHODS

We enrolled 1871 consecutive patients who underwent coronary angiography for evaluation of symptoms suggestive of CAD in the BOREAS-CAG Registry between August 2014 and January 2015. After exclusion of patients with valvular heart disease or a history of PCI/cardiac surgery, 1150 patients contributed to multivariate logistic regression analysis to identify risk factors of AF. We also retrieved data for 361 consecutive patients with CAD admitted to Sapporo Medical University Hospital between April 2013 and July 2014 and analysed data for 166 patients using the same inclusion and exclusion criteria as those in the BOREAS-CAG Registry.

RESULTS

Unexpectedly, CAD was independently associated with the absence of AF. The patients were then divided into a non-CAD group (n=576) and a CAD group (n=574) for further analysis. The brain natriuretic peptide level showed a strong association with AF regardless of the presence or absence of CAD. In the non-CAD group, lack of statin use was independently associated with AF, whereas high serum uric acid level was an independent explanatory variable of AF in the CAD group. The association of AF with uric acid was confirmed in a separate group of patients (n=166) enrolled in the CAD cohort in Sapporo Medical University Hospital.

CONCLUSIONS

Major risk factors of AF are different in patients with CAD and those without CAD. Patients with CAD are more likely to develop AF when the serum uric acid level is high, whereas no statin administration predicts development of AF in patients without CAD.

摘要

目的

虽然一般人群中心房颤动(AF)的危险因素已得到明确,但它们对特定疾病患者的影响尚不清楚。我们的目的是确定患有和未患有冠状动脉疾病(CAD)的患者中AF的危险因素是否不同。

方法

我们纳入了2014年8月至2015年1月期间在BOREAS-CAG注册研究中因疑似CAD症状而接受冠状动脉造影的1871例连续患者。排除患有瓣膜性心脏病或有PCI/心脏手术史的患者后,1150例患者参与多因素逻辑回归分析以确定AF的危险因素。我们还检索了2013年4月至2014年7月期间入住札幌医科大学医院的361例连续CAD患者的数据,并使用与BOREAS-CAG注册研究相同的纳入和排除标准对166例患者的数据进行了分析。

结果

出乎意料的是,CAD与无AF独立相关。然后将患者分为非CAD组(n = 576)和CAD组(n = 574)进行进一步分析。无论是否存在CAD,脑钠肽水平均与AF密切相关。在非CAD组中,未使用他汀类药物与AF独立相关,而高血清尿酸水平是CAD组中AF的独立解释变量。在札幌医科大学医院CAD队列中纳入的另一组患者(n = 166)中证实了AF与尿酸的关联。

结论

CAD患者和非CAD患者中AF的主要危险因素不同。CAD患者在血清尿酸水平高时更易发生AF,而未服用他汀类药物则预示非CAD患者会发生AF。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d5/5255559/dcde3559e036/openhrt2016000573f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d5/5255559/dcde3559e036/openhrt2016000573f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d5/5255559/dcde3559e036/openhrt2016000573f01.jpg

相似文献

1
Distinct risk factors of atrial fibrillation in patients with and without coronary artery disease: a cross-sectional analysis of the BOREAS-CAG Registry data.有和无冠状动脉疾病患者心房颤动的不同危险因素:BOREAS-CAG注册研究数据的横断面分析
Open Heart. 2017 Jan 16;4(1):e000573. doi: 10.1136/openhrt-2016-000573. eCollection 2017.
2
Impact of coronary artery disease and revascularization on recurrence of atrial fibrillation after catheter ablation: Importance of ischemia in managing atrial fibrillation.冠心病及血运重建对导管消融术后心房颤动复发的影响:缺血在心房颤动管理中的重要性。
J Cardiovasc Electrophysiol. 2019 Sep;30(9):1491-1498. doi: 10.1111/jce.14029. Epub 2019 Jun 25.
3
Angiographic profile and outcomes in persistent non-valvular atrial fibrillation: A study from tertiary care center in North India.持续性非瓣膜性心房颤动的血管造影特征和结局:来自印度北部三级护理中心的研究。
Indian Heart J. 2022 Jan-Feb;74(1):7-12. doi: 10.1016/j.ihj.2021.12.010. Epub 2021 Dec 24.
4
Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status - Report From the Japanese Nationwide Multicenter Registry.根据冠状动脉疾病状态,射血分数保留的心力衰竭住院患者心房颤动的预后差异影响 - 来自日本全国多中心登记处的报告。
Circ J. 2020 Feb 25;84(3):397-403. doi: 10.1253/circj.CJ-19-0963. Epub 2020 Feb 1.
5
A Newly Defined CHADS-VA Score for Predicting Obstructive Coronary Artery Disease in Patients with Atrial Fibrillation-A Cross-Sectional Study of Older Persons Referred for Elective Coronary Angiography.一种新定义的CHADS-VA评分用于预测心房颤动患者的阻塞性冠状动脉疾病——一项针对接受择期冠状动脉造影的老年人的横断面研究。
J Clin Med. 2022 Jun 16;11(12):3462. doi: 10.3390/jcm11123462.
6
Characteristics of coronary artery disease among patients with atrial fibrillation compared to patients with sinus rhythm.与窦性心律患者相比,房颤患者的冠状动脉疾病特征。
Hellenic J Cardiol. 2017 May-Jun;58(3):204-212. doi: 10.1016/j.hjc.2017.03.001. Epub 2017 Mar 11.
7
Relationship of Provider and Practice Volume to Performance Measure Adherence for Coronary Artery Disease, Heart Failure, and Atrial Fibrillation: Results From the National Cardiovascular Data Registry.医疗服务提供者及诊疗量与冠心病、心力衰竭和心房颤动性能指标依从性的关系:来自国家心血管数据注册库的结果
Circ Cardiovasc Qual Outcomes. 2016 Jan;9(1):48-54. doi: 10.1161/CIRCOUTCOMES.115.002159. Epub 2015 Dec 8.
8
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.房颤合并冠心病患者的抗血栓治疗。
BMC Cardiovasc Disord. 2020 Jul 6;20(1):323. doi: 10.1186/s12872-020-01609-8.
9
Impact of Stable Coronary Artery Disease on the Efficacy of Cryoballoon Ablation for the Atrial Fibrillation.稳定性冠状动脉疾病对冷冻球囊消融治疗心房颤动疗效的影响。
Am J Med Sci. 2019 Sep;358(3):204-211. doi: 10.1016/j.amjms.2019.06.004. Epub 2019 Jun 21.
10
Secondary prevention and outcomes in outpatients with coronary artery disease, atrial fibrillation or heart failure: a focus on disease overlap.冠心病、心房颤动或心力衰竭门诊患者的二级预防及结局:关注疾病重叠情况
Open Heart. 2020 Apr 21;7(1):e001165. doi: 10.1136/openhrt-2019-001165. eCollection 2020.

引用本文的文献

1
The identification and prediction of atrial fibrillation in coronary artery disease patients: a multicentre retrospective study based on Bayesian network.基于贝叶斯网络的冠心病患者心房颤动的识别和预测:一项多中心回顾性研究。
Ann Med. 2024 Dec;56(1):2423789. doi: 10.1080/07853890.2024.2423789. Epub 2024 Nov 7.
2
The Relationship between Uric Acid and the Development, Complication, and Prognosis of Atrial Fibrillation: The Views from a Clinical Study.尿酸与心房颤动的发生、并发症及预后的关系:一项临床研究的观点
Int J Endocrinol. 2022 Oct 27;2022:9355504. doi: 10.1155/2022/9355504. eCollection 2022.
3
Comparison of prognosis and outcomes of catheter ablation versus drug therapy in patients with atrial fibrillation and stable coronary artery disease: A prospective propensity-score matched cohort study.

本文引用的文献

1
Racial and ethnic differences in atrial fibrillation risk factors and predictors in women: Findings from the Women's Health Initiative.女性房颤风险因素及预测指标的种族和民族差异:来自女性健康倡议的研究结果
Am Heart J. 2016 Jun;176:70-7. doi: 10.1016/j.ahj.2016.03.004. Epub 2016 Mar 17.
2
Allopurinol and the risk of atrial fibrillation in the elderly: a study using Medicare data.别嘌醇与老年人心房颤动风险:一项基于医疗保险数据的研究。
Ann Rheum Dis. 2017 Jan;76(1):72-78. doi: 10.1136/annrheumdis-2015-209008. Epub 2016 May 10.
3
Perioperative Rosuvastatin in Cardiac Surgery.
比较导管消融与药物治疗在合并心房颤动和稳定型冠状动脉疾病患者中的预后和结局:一项前瞻性倾向评分匹配队列研究。
Clin Cardiol. 2021 Oct;44(10):1422-1431. doi: 10.1002/clc.23699. Epub 2021 Jul 28.
4
The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation.尿酸在心房颤动发病机制中的氧化应激、炎症、纤维化、细胞凋亡及免疫过程中的关键作用
Front Cardiovasc Med. 2021 Feb 26;8:641136. doi: 10.3389/fcvm.2021.641136. eCollection 2021.
5
Common differentially expressed genes and pathways correlating both coronary artery disease and atrial fibrillation.与冠状动脉疾病和心房颤动均相关的常见差异表达基因和通路。
EXCLI J. 2021 Jan 18;20:126-141. doi: 10.17179/excli2020-3262. eCollection 2021.
6
Atrial fibrillation risk factors in patients with ischemic stroke.缺血性脑卒中患者的房颤危险因素
Arch Med Sci. 2019 Apr 5;17(1):19-24. doi: 10.5114/aoms.2019.84212. eCollection 2021.
7
Risk Factors of Atrial Fibrillation in Patients with Heart Failure.心力衰竭患者心房颤动的危险因素
Cureus. 2018 Dec 24;10(12):e3774. doi: 10.7759/cureus.3774.
8
Predictive value of CHADS and CHADS-VASc scores for acute myocardial infarction in patients with atrial fibrillation.CHA2DS2-VASc 评分对合并心房颤动患者急性心肌梗死的预测价值。
Sci Rep. 2017 Jul 5;7(1):4730. doi: 10.1038/s41598-017-04604-w.
心脏手术中的围手术期瑞舒伐他汀。
N Engl J Med. 2016 May 5;374(18):1744-53. doi: 10.1056/NEJMoa1507750.
4
Statin Antiarrhythmic Effect on Atrial Fibrillation in Statin-Naive Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials.他汀类药物对接受心脏手术的初治患者房颤的抗心律失常作用:一项随机对照试验的荟萃分析
J Cardiovasc Pharmacol Ther. 2016 Mar;21(2):167-76. doi: 10.1177/1074248415602557. Epub 2015 Sep 1.
5
Renal dysfunction and the risk of postoperative atrial fibrillation after cardiac surgery: role beyond the CHA2DS2-VASc score.心脏手术后的肾功能不全与术后房颤风险:超越CHA2DS2-VASc评分的作用
Europace. 2015 Sep;17(9):1363-70. doi: 10.1093/europace/euu360. Epub 2015 Feb 5.
6
Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis.血清尿酸与心房颤动之间的关联:一项系统评价和荟萃分析。
Heart Rhythm. 2014 Jul;11(7):1102-8. doi: 10.1016/j.hrthm.2014.04.003. Epub 2014 Apr 5.
7
Effect of preoperative obstructive sleep apnea on the frequency of atrial fibrillation after coronary artery bypass grafting.术前阻塞性睡眠呼吸暂停对冠状动脉旁路移植术后心房颤动发生率的影响。
Am J Cardiol. 2014 Mar 15;113(6):919-23. doi: 10.1016/j.amjcard.2013.11.047. Epub 2013 Dec 25.
8
Usefulness of right ventricular dysfunction to predict new-onset atrial fibrillation following coronary artery bypass grafting.右心室功能障碍预测冠状动脉旁路移植术后新发心房颤动的价值。
Am J Cardiol. 2014 Mar 15;113(6):913-8. doi: 10.1016/j.amjcard.2013.11.048. Epub 2013 Dec 25.
9
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.全球心房颤动流行病学:2010 年全球疾病负担研究。
Circulation. 2014 Feb 25;129(8):837-47. doi: 10.1161/CIRCULATIONAHA.113.005119. Epub 2013 Dec 17.
10
Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study.黄嘌呤氧化酶抑制用于高尿酸血症心力衰竭患者:EXACT-HF研究的设计与原理
Circ Heart Fail. 2013 Jul;6(4):862-8. doi: 10.1161/CIRCHEARTFAILURE.113.000394.